{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Fox chase cancer center"
  ],
  "article_type": "New results",
  "arxiv": null,
  "author_total": 12,
  "authors": [
    {
      "name": "N. Pattabiraman"
    },
    {
      "name": "C. Lobello"
    },
    {
      "name": "D. Rushmore"
    },
    {
      "name": "S. Wang"
    },
    {
      "name": "L. Mologni"
    },
    {
      "name": "H. Borgh"
    },
    {
      "name": "K. Nath"
    },
    {
      "name": "W. Zhang"
    },
    {
      "name": "A. Goldman"
    },
    {
      "name": "R. Nejati"
    },
    {
      "name": "M. Wasik"
    },
    {
      "affs": [
        0
      ],
      "name": "J. Basappa"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/d16p6k2kmykr6.bib",
  "cited_by": 0,
  "doi": "10.64898/2026.09.29.755331",
  "fulltext_url": "https://www.biorxiv.org/content/10.64898/2026.09.29.755331v1.full",
  "id": "d16p6k2kmykr6",
  "issns": [],
  "landing_url": "https://www.biorxiv.org/content/10.64898/2026.09.29.755331v1",
  "language": null,
  "licence": "LicenseRef-all-rights-reserved",
  "licence_label": "All rights reserved",
  "licence_source": "article",
  "licence_url": null,
  "metadata_licence": null,
  "native_subjects": [
    [
      "biorxiv",
      "cancer biology"
    ],
    [
      "openalex",
      "1306|Cancer, Lipids, and Metabolism"
    ]
  ],
  "openalex": "W7219804275",
  "pdf_url": "https://www.biorxiv.org/content/10.64898/2026.09.29.755331v1.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-09-29",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/d16p6k2kmykr6.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:25:57Z",
      "native_id": "10.64898/2026.09.29.755331",
      "source": "biorxiv",
      "url": "https://www.biorxiv.org/content/10.64898/2026.09.29.755331v1"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "biorxiv:cancer biology",
      "subfield": "oncology"
    }
  ],
  "title": "A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma",
  "title_text": "A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma",
  "type": "preprint",
  "updated_at": "2026-10-30T12:25:57Z",
  "url": "https://research.draconitic.com/paper/d16p6k2kmykr6",
  "venue": "bioRxiv",
  "versions": []
}